Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -32.083 | -30.844 | -43.296 | -55.112 | -56.963 | -42.938 | -66.943 | -47.3 |
Return on Equity (%) | -34.733 | -33.107 | -46.784 | -61.924 | -65.992 | -49.934 | -78.183 | -57.623 |
Return on Invested Capital (%) | -36.386 | -34.014 | -47.821 | -63.064 | -48.284 | -60.028 | -77.67 | -54.106 |
Operating Margin (%) | -99.399 | -103.03 | -153.204 | -142.772 | -135.623 | -131.007 | -197.705 | -131.287 |
Net Profit Margin (%) | -99.445 | -102.213 | -153.388 | -142.863 | -183.326 | -131.067 | -198.026 | -131.873 |
Book Value Per Share | 6.247 | 6.419 | 4.105 | 3.341 | 4.542 | 2.809 | 2.77 | 1.217 |
Earnings Per Share | -2.058 | -2.21 | -2.731 | -2.636 | -2.626 | -2.051 | -2.95 | -2.256 |
Cash Per Share | 1.105 | 3.501 | 2.292 | 0.9 | 1.176 | 0.814 | 1.658 | 1.053 |
Working Capital Per Share | 5.55 | 6.112 | 3.809 | 3.039 | 4.423 | 2.141 | 2.664 | 1.206 |
Operating Profit Per Share | 1.455 | 1.614 | 1.247 | 1.362 | 1.084 | 1.162 | 1.043 | 1.264 |
EBIT Per Share | -2.057 | -2.228 | -2.728 | -2.635 | -1.943 | -2.05 | -2.945 | -2.246 |
EBITDA Per Share | -2.057 | -2.228 | -2.728 | -2.635 | -1.943 | -2.05 | -2.945 | -2.246 |
Free Cash Flow Per Share | -2.001 | -2.138 | -2.734 | -2.661 | -2.654 | -2.073 | -3.217 | -2.546 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 10,52M | 11,65M | 11,89M | 12,45M | 16,74M | 16,94M | 20,26M | N/A |
Fin d'année 31 Décembre 2023 | Sept 2022 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 20,04M | 20,26M | N/A | 20,33M | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | -178.784 | N/A | N/A | N/A | -103.934 | N/A |
Net Profit Margin (%) | N/A | N/A | -179.013 | N/A | N/A | N/A | -104.025 | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 671,97M |
Ratio cours/bénéfice | -15,23 |
Ratio prix/ventes | 20,09 |
Ratio prix/liquidités | 32,62 |
Ratio prix/valeur comptable | 11,3 |
Rendement de dividende | - |
Actions en circulation | 21,42M |
Volume moyen (1 semaine) | 264,3k |
Volume moyen (1 mois) | 136,97k |
Variation sur 52 semaines | -2,51% |
Plus haut sur 52 semaines | 43,43 |
Plus bas sur 52 semaines | 21,00 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales